Overview
Methylprednisolone is a synthetic glucocorticoid with potent anti-inflammatory and immunosuppressive properties. It is used to treat various inflammatory, allergic, and autoimmune conditions by suppressing immune responses and reducing inflammation. Dosage must be individualized based on disease severity and patient response, with gradual tapering when discontinuing long-term therapy.
Mechanism of Action
Methylprednisolone binds to glucocorticoid receptors, modulating gene expression to inhibit inflammatory mediators (cytokines, chemokines, adhesion molecules) and immune cell function. It suppresses neutrophil migration, reduces capillary permeability, and stabilizes lysosomal membranes, leading to decreased inflammation and immune response.
Indications
- Inflammatory conditions (e.g., rheumatoid arthritis, lupus)
- Allergic disorders
- Dermatologic diseases
- Respiratory conditions (e.g., asthma exacerbations)
- Hematologic disorders
- Ophthalmic inflammatory conditions
- Gastrointestinal diseases (e.g., ulcerative colitis)
- Nephrotic syndrome
- Cerebral edema
- Adrenal insufficiency
Common Doses
- 4 mg
- 8 mg
- 16 mg
- 32 mg
Dosage
Initial dosage ranges from 4 mg to 48 mg daily depending on disease severity, with maintenance doses determined by gradual reduction to the lowest effective dose. Dosage must be individualized and adjusted based on clinical response, with increased doses during stressful situations. Taper gradually when discontinuing long-term therapy.
Contraindications
- Systemic fungal infections
- Known hypersensitivity to methylprednisolone or components
Side Effects
- Fluid retention, hypertension, hypokalemia
- Muscle weakness, osteoporosis, tendon rupture
- Peptic ulcer, pancreatitis, impaired wound healing
- Increased intracranial pressure, headache, vertigo
- Cushingoid appearance, growth suppression in children
- Glucose intolerance, diabetes mellitus exacerbation
- Skin thinning, easy bruising, facial erythema
- Adrenal insufficiency, menstrual irregularities
- Elevated liver enzymes (usually reversible)
Interactions
- Cyclosporine: increased risk of adverse effects and convulsions
- Enzyme inducers (phenobarbital, phenytoin, rifampin): decreased methylprednisolone levels
- Enzyme inhibitors (ketoconazole, troleandomycin): increased methylprednisolone levels
- Aspirin: altered clearance and salicylate levels
- Anticoagulants: variable effects on coagulation
Counseling Points
- Take exactly as prescribed; do not stop abruptly
- Report signs of infection, vision changes, or unusual swelling
- Monitor blood glucose if diabetic
- Carry medical identification indicating steroid use
- Inform all healthcare providers about methylprednisolone use
- Avoid live vaccines while on therapy
- Report stomach pain, black stools, or muscle weakness